These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 33814126

  • 1. Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial.
    Giles J, Alama P, Gamiz P, Vidal C, Badia P, Pellicer A, Bosch E.
    Fertil Steril; 2021 Aug; 116(2):404-412. PubMed ID: 33814126
    [Abstract] [Full Text] [Related]

  • 2. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial.
    Beguería R, García D, Vassena R, Rodríguez A.
    Hum Reprod; 2019 May 01; 34(5):872-880. PubMed ID: 30927417
    [Abstract] [Full Text] [Related]

  • 3. Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology.
    Yildiz S, Turkgeldi E, Angun B, Eraslan A, Urman B, Ata B.
    Fertil Steril; 2019 Oct 01; 112(4):677-683. PubMed ID: 31371053
    [Abstract] [Full Text] [Related]

  • 4. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S, Long H, Chang HY, Liu Y, Gao H, Zhu J, Quan X, Lyu Q, Kuang Y, Ai A.
    Hum Reprod; 2018 Feb 01; 33(2):229-237. PubMed ID: 29300975
    [Abstract] [Full Text] [Related]

  • 5. [Medroxyprogesteron acetate use to block LH surge in oocyte donor stimulation].
    Crha I, Ventruba P, Filipinská E, Dziakova M, Žáková J, Ješeta M, Lousová E, Papíková Z.
    Ceska Gynekol; 2018 Feb 01; 83(1):11-16. PubMed ID: 29510633
    [Abstract] [Full Text] [Related]

  • 6. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN, Ho MT, Ha TD, Phung HT, Huynh GB, Humaidan P.
    Fertil Steril; 2016 Feb 01; 105(2):356-63. PubMed ID: 26523330
    [Abstract] [Full Text] [Related]

  • 7. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
    Kuang Y, Chen Q, Fu Y, Wang Y, Hong Q, Lyu Q, Ai A, Shoham Z.
    Fertil Steril; 2015 Jul 01; 104(1):62-70.e3. PubMed ID: 25956370
    [Abstract] [Full Text] [Related]

  • 8. The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial.
    Dong J, Wang Y, Chai WR, Hong QQ, Wang NL, Sun LH, Long H, Wang L, Tian H, Lyu QF, Lu XF, Chen QJ, Kuang YP.
    BJOG; 2017 Jun 01; 124(7):1048-1055. PubMed ID: 28276192
    [Abstract] [Full Text] [Related]

  • 9. Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles.
    Vidal MDM, Martínez F, Rodríguez I, Polyzos NP.
    Hum Reprod; 2024 May 02; 39(5):1098-1104. PubMed ID: 38498835
    [Abstract] [Full Text] [Related]

  • 10. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN, Phung HT, Ho MT.
    Hum Reprod; 2015 May 02; 30(5):1188-95. PubMed ID: 25740882
    [Abstract] [Full Text] [Related]

  • 11. Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.
    Wang Y, Chen Q, Wang N, Chen H, Lyu Q, Kuang Y.
    Medicine (Baltimore); 2016 Mar 02; 95(9):e2939. PubMed ID: 26945402
    [Abstract] [Full Text] [Related]

  • 12. Exposure of antral follicles to medroxyprogesterone acetate during stimulation does not cause molecular perturbations in gonadotropin-responsiveness and steroidogenic function of granulosa cells in progestin-primed cycles.
    Oktem O, Esmaeilian Y, İltumur E, Yusufoglu S, Çimen DU, Incir S, Yakin K, Ata B, Urman B.
    Hum Reprod; 2024 Oct 01; 39(10):2331-2340. PubMed ID: 39180767
    [Abstract] [Full Text] [Related]

  • 13. Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial.
    Wang Y, Kuang Y, Chen Q, Cai R.
    Trials; 2018 Aug 22; 19(1):455. PubMed ID: 30134964
    [Abstract] [Full Text] [Related]

  • 14. Oral medroxyprogesterone acetate for the use of ovulation suppression in in vitro fertilization: a cohort trial.
    Welp AM, Williams CD, Smith LP, Purcell S, Goodman LR.
    Fertil Steril; 2024 May 22; 121(5):806-813. PubMed ID: 38253117
    [Abstract] [Full Text] [Related]

  • 15. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS.
    Fertil Steril; 2006 Jul 22; 86(1):58-63. PubMed ID: 16753156
    [Abstract] [Full Text] [Related]

  • 16. Fixed Gonadotropin-Releasing Hormone Antagonist Protocol Versus Flexible Progestin-Primed Ovarian Stimulation Protocol in Patients With Asynchronous Follicular Development During Controlled Ovulation Stimulation: A Retrospective Study.
    Dong M, Sun L, Huang L, Wang F, Zhang X, Liu F.
    Front Endocrinol (Lausanne); 2021 Jul 22; 12():690575. PubMed ID: 34867773
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes.
    Martínez F, Clua E, Devesa M, Rodríguez I, Arroyo G, González C, Solé M, Tur R, Coroleu B, Barri PN.
    Fertil Steril; 2014 Nov 22; 102(5):1307-11. PubMed ID: 25154677
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.